Dr. Barry Dworkin

If approved based on review of study data, oral COVID Drug mulnupiravir may help reduce hospitalization and risk of death for specific at-risk populations.

Medical Mythbusting Commentary for October 4, 2021

Source:
Oral COVID Drug Slashes Hospitalization and Death Risk, Merck Says

Related posts:

  1. Sunday House Call, #730, March 15, 2020: Dr. Vera Etches, Chief Medical Health Officer for Ottawa answers many questions about Coronavirus.
  2. Recent Sars-Cov-2 data analysis shows the efforts of Canadians is starting to have a positive effect. Don’t let up.
  3. A grand bargain to try to make school work and convince parents of its merits. Plan is predicated on many assumptions and limited evidence.
  4. Still no evidence we can live past 130 years of age despite study’s extrapolation of data. — ICU doctor provides firsthand account of the needless suffering endured by people with COVID, their loved ones, and by those caring for them. #VaccinesWork